Drugs / Rillus®
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT03568812 | May → Dec 2018 | HIV infectious disease, immunodeficiency disease | Indonesia University | Completed | Met primary |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Rillus | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03568812 ↗ |